In the last AE37 study, 89% were disease free at 55 months. I read somewhere that Keytruda is not effective for 20-30% of patients. So, hopefully combining the two will lead to great results. Dare we wish for 100%?
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
